HBIO - HARVARD BIOSCIENCE INC

5.41
-1.430   -26.433%

Share volume: 52,865
Last Updated: 05-12-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.07%

PREVIOUS CLOSE
CHG
CHG%
$6.84
-1.43
-0.21%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 13%
Liquidity 20%
Performance 12%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-21.54%
1 Month
16.22%
3 Months
875.48%
6 Months
829.23%
1 Year
1,359.79%
2 Year
59.59%
Key data
Stock price
$5.41
P/E Ratio 
N/A
DAY RANGE
$5.41 - $6.40
EPS 
-$1.28
52 WEEK RANGE
$0.28 - $7.50
52 WEEK CHANGE
$1,464.04
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
44.720 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
BETA 
1.69
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$43,083
AVERAGE 30 VOLUME 
$50,088
Company detail
CEO: James W. Green
Region: US
Website: harvardbioscience.com
Employees: 490
IPO year: 2001
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as instruments and accessories for tissue and organ-based lab research.

Recent news